Books - Non-fiction

Bispecific t-cell activator antibody

Description
This invention relates to bispecific antibodies having combinations of linker and hinge sequences to create linker-hinge interface domains with biological significance. Such linker-hinge interface domains covalently join two molecules, maintain the
Published
of 22
All materials on our website are shared by users. If you have any questions about copyright issues, please report us to resolve them. We are always happy to assist you.
Related Documents
Share
Transcript
  US 20130165629A1 19) United States 12) Patent Application Publication 10) Pub. No.: US 2013/0165629 A1 Hsu et al. 43) Pub. Date: Jun. 27, 2013 (54) BISPECIFIC T-CELL ACTIVATOR ANTIBODY Publication Classi?cation 71) ApplicantszDevelopment Center for 51) Int. Cl. Biotechnology, New aipei City (TW); C07K 6/46 (2006.01) DCB-USA LLC; Wilmington, DE (U ) C07K 7/06 (2006.01) C07K 7/08 (2006.01) 72) Inventors: Yu-Shen Hsu; NeW aipei City (TW); 52) us CL shew-Shall Shell, New aipei City CPC ............... .. C07K16/468 (2013.01); C07K 7/08 (TW); Mingi Chang, New aipei City 2013.01); C07K 7/06 (2013.01) (TW); Ming-Ch“an Chang, New aipei USPC ....................... 530/326; 530/3873; 530/328 City (TW); Ta-Tung Yuan; NeW aipei City (TW) 57) ABSTRACT This invention relates to bispeci?c antibodies having combi (73) Assigneesr DCB-USA LLC, Wilmington, DE (Us); nations of linker and hinge sequences to create linker-hinge DEVELOPMENT CENTER FOR interface domains With biological signi?cance. Such linker BIOTECHNOLOGY, NeW aipei City hinge interface domains covalently join tWo molecules; main (TW) tain the biological activities of linked molecules target bind ing); stabilize the biological characteristics of neW molecule (solubility and 40 C. stability); maintain the chemical; bio 21) Appl NO 13/720,573 chemical and physical properties cytotoxicity) of the linked molecules; and modulate the biological characteristics of the 22) Filed: Dec. 19, 2012 linked molecules activating T-lymphocytes Without signi? cant sign of roliferations). Both linker (GGGGS) and hinge CPPCP) sequences are required to establish functional Related U s Apphcatlon Data linker-hinge interface domains as deletion of any of the com (60) Provisional application No. 61/ 79,450; ?led on Dec. ponent resulted in signi?cant lost of T-lymphocyte mediated 22, 2011. activity.   301 oas ? ass“ ??véun 3? U 2013 0165629 A1 2:15 2”; 522: oting“ EEsH Jun. 27 2013 Sheet 0f 14 9 m muéqa EEEQ oming“; 5559 E ?mv £ Qmoue?dmHéowwiomswmoai SwE Patent Application Publication  Patent Application Publication Jun. 27 2 13 Sheet 2 0f 14 US 2013/0165629 A1 MB 2522: S31E83 EEFH 5.25 c?iwoua 5558 ‘ Axiom QU? EV 5 .25 5333.» ? :6 -255 mii E: Eu om u w mm NQUAES M? iommoqu dmwwowwcm ii : 55  Patent Application Publication Jun. 27 2 13 Sheet 3 0f 14 US 2013/0165629 A1 S325 a?a 3 25 25 min iim 051i NQOAEB MH ugen ating? EDH QMTQQL £ mam???mwowo?cmqéaowwiomsauai 5mm  5 m 0 25 i im bow nwakéum ? U 2013 0165629 A1 ESQ? is: ame wse EEQG wii x51 20 ”; 2522: izawou? 5555 Jun. 27 2013 Sheet 4 0f 14 2 20 ?5 ? 52.5 c?EmoR? EESH ., Patent Application Publication
Search
Similar documents
View more...
Tags
Related Search
We Need Your Support
Thank you for visiting our website and your interest in our free products and services. We are nonprofit website to share and download documents. To the running of this website, we need your help to support us.

Thanks to everyone for your continued support.

No, Thanks